BIOMARKER‐DRIVEN TREATMENT STRATEGY IN HIGH RISK DIFFUSE LARGE B‐CELL LYMPHOMA: RESULTS OF A NORDIC PHASE 2 STUDY
- S Leppa (Author)
- J Jørgensen (Co-author)
- ML Karjalainen-Lindsberg (Co-author)
- Beiske K. (Co-author)
- P. Nørgaard (Co-author)
- K. Drott (Co-author)
- Pasanen A (Co-author)
- Karihtala K (Co-author)
- Mannisto S. (Co-author)
- Wold B (Co-author)
- Brodtkorb M. (Co-author)
- M Fagerli (Co-author)
- Thomas Stauffer Larsen (Co-author)
- Lars Munksgaard (Co-author)
- Ø Fluge (Co-author)
- S Jyrkkiö (Co-author)
- Peter de Nully Brown (Co-author)
- H. Holte (Co-author)
Activity: Talks and presentations › Conference presentations